Experience with Two Different Nonthoracotomy Systems for Implantable Defibrillator in 170 Patients

• Published in: Pacing and clinical electrophysiology 1994-11, Vol.17 (11), p.1741-1750
• Main Authors: SRA, JASBIR S., NATALE, ANDREA, AXTELL, KATHI, MAGLIO, CHERYL, JAZAYERI, MOHAMMAD, DESHPANDE, SANJAY, DHALA, ANWER, BLANCK, ZALMEN, AKHTAR, MASOOD
• Format: Article
• Language: English
• Subjects: Anti-Arrhythmia Agents - therapeutic use; Defibrillators, Implantable - adverse effects; Female; Humans; Male; Middle Aged; nonthoracotomy system; Survival Rate; Tachycardia, Ventricular - mortality; Tachycardia, Ventricular - therapy; Thoracotomy; ventricular arrhythmias; Ventricular Fibrillation - mortality; Ventricular Fibrillation - therapy
• ISSN: 0147-8389; 1540-8159
• DOI: 10.1111/j.1540-8159.1994.tb03741.x

Implantation of a nonthoracotomy system (Medtronic PCD or CPI Endotak) was attempted in 170 patients with ventricular tachycardia (VT) or ventricular fibrillation (VF) not requiring concomitant cardiac surgery. A nonthoracotomy system could be successfully implanted in 95 of the 115 patients with the PCD system and 49 of 55 patients receiving the Endotak lead system. In 26 patients with failed nontboracotomy system because of defibrillation threshold (DFT) > 25 joules (J), an epicardial system was implanted at the same setting. Patients receiving the two lead systems were comparable with regard to age, sex, and ejection fraction. However, since tbe PCD system offers tiered therapy multiprogrammable options, all attempts were made to implant tbis lead system in patients with VT that could be pace terminated. Mean DFT(15 ± 4.7 vs 17 ± 4.6 J;P = 0.03) and implant time (2.5 ± 0.6 vs 3.3 ± 0.7 hours; P = 0.02) were less with the Endotak lead system. There was no perioperative mortality. During a mean follow‐up of 20 ± 4 months, there were eight instances of lead dislodgment in patients receiving the PCD system. Tbere were four nonsudden cardiac deaths and one sudden death in the Endotak group and three nonsudden deaths in the PCD group. Sudden cardiac death and total survival using the intention‐to‐treat analysis during this follow‐up period were 99% and 95%, respectively. In conclusion, successful implantation, perioperative mortality, and survival rate are comparable with both lead systems; however, incorporating two defibrillating electrodes in one lead minimizes lead dislodgment and reduces implant time.